Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Back to Contracts

Medical Product Supply – Psyllium Hydrophilic Mucilloid

Active

Federal

Response Deadline07/28/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract calls for the supply of FDA-regulated Psyllium Hydrophilic Mucilloid in 12-gram packets, with strict specifications for potassium and sodium content to ensure compliance with medical standards. Each packet must be manufactured under the part number NDC37000-0740-87 and carry a non-extendable 24-month shelf life, requiring careful production and inventory management to maintain product integrity through distribution and use. The product is intended for military medical use, with performance located at Camp Pendleton, California, 92055-5627, and is classified under NAICS code 325411 for pharmaceutical and medicine manufacturing. This subcontract is solicited by the Department of Defense under the Medical Supply Chain Pharm FSA, with responses due by July 28, 2026, and the posting date was July 22, 2026. No set-aside provisions apply, and the contract is open to qualified suppliers meeting all technical and regulatory requirements.

General Info

Supply FDA-compliant 12g Psyllium packets, NDC37000-0740-87, 24-month shelf life, for military use at Camp Pendleton.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325411 - Medicinal and Botanical ManufacturingView NAICS

Place of Performance

CAMP PENDLETON, CA, 92055-5627, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJul 22

subcontract

Response DeadlineJul 28

Submission deadline

Response Deadline

07/28/2026, 05:00:00 PM UTCin 2 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Supply of FDA-regulated Psyllium Hydrophilic Mucilloid in 12-gram packets with specific potassium and sodium content, non-extendable 24-month shelf life, and manufacturer part number NDC37000-0740-87.

Similar Contracts

Same NAICS industry code

REHYDRATION SALTS FORThe contract specifies the procurement of 5 packages of Rehydration Salts for Oral Solution, Orange Flavor, 21 grams each, under NSN 6505-01-687-1441, with a unit of issue of PACKAGE and a total value of $5.00. Delivery is required FOB destination within 20 days of contract award, with no variance allowed in quantity, and inspection and acceptance occur at the delivery point. The product must comply with strict packaging and labeling requirements per DLA’s Master List of Technical and Quality Requirements, specifically referencing Medical Marking Standard No. 1, which replaces MIL-STD-129, and must be commercially packaged in accordance with ASTM D3951 unless classified as hazardous, in which case Fed-Std-313 and IP025 apply. The item is a Type I (Code Q) medical product with a non-extendable shelf life of 36 months, and all packaging must be marked in full compliance with MMS No. 1, obtainable via DLA Troop Support or their public website. The destination for delivery is USS Tulsa (LCS-16), FPO AP 96691, with shipment handling governed by DLAD Proc Notes C19 and C20. The contract, issued under solicitation SPE2DP-26-T-4259, is for a federal acquisition with a response deadline of July 29, 2026, and the required delivery date is July 27, 2026. The supplier is Drip Drop Hydration Inc., identified by P/N 61410, and full technical and quality specifications are governed by DLA standards that supersede all other references.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SCOPOLAMINE TRANSDERMAThe contract specifies the procurement of 6 boxes of Scopolamine Transdermal System, each containing 10 patches delivering 1.5 mg over a three-day period, with the product identified by NSN 6505-01-692-5042 and NDC 10019-0553-03 from Baxter Healthcare Corporation. All units must be packaged in sealed commercial containers that protect against damage and breakage, shipped in suitable exterior containers to ensure safe, cost-effective delivery to Fort Bragg, North Carolina, within five days of contract award. Packaging must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and adhere to DLA Packaging Requirements for Procurement, including palletization and marking in accordance with the latest MMS No. 1 guidelines. The product has a non-extendable shelf life of 36 months and must be stored at controlled room temperature between 68°F and 77°F, with pouches kept upright and never bent or rolled. Delivery is FOB destination, with inspection and acceptance occurring at the delivery point, and no quantity variance is permitted. The shipment must be sent by the fastest traceable means, excluding parcel post, and all documentation must reflect the required government markings, logistics identifiers, and special handling instructions. The contract is issued under solicitation SPE2DP-26-T-4267 with a required delivery date of July 27, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BENZOCAINE AND MENTHOLThe contract is for the procurement of Benzocaine and Menthol Lozenge, specifically CEPACOL EXTRA STRENGTH SORE THROAT HONEY LEMON LOZENGES, each containing 15 mg of benzocaine and 2.6 mg of menthol, packaged in quantities of 16 lozenges per unit. The product must be stored at 20–25°C (68–77°F) and protected from humidity. All packaging must comply with commercial standards as outlined in the procurement document, with each unit sealed in a container that prevents damage or breakage, and shipped in exterior containers that ensure safe, low-cost delivery by common carriers to the designated destination. Medical marking requirements follow Medical Marking Standard No. 1, which replaces MIL-STD-129, and suppliers must adhere to DLA’s packaging guidelines and shelf-life requirement of 36 months with no extensions permitted. The item is identified by NSN 6505-01-708-1449 and NDC 63824-0732-16, supplied by Reckitt Benckiser LLC and RB Health US LLC. Delivery is required within 20 days, FOB destination, with zero variance allowed in quantity and inspection and acceptance occurring upon delivery. The shipment must be traceable, excluding parcel post, and delivered to Fort Campbell, Kentucky. Special handling instructions, including palletization and packaging methods, must align with DLA’s technical and quality standards referenced in the Master List, and all markings and documentation must conform to required government protocols for medical acquisitions.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SUMATRIPTAN SUCCINATESumatriptan Succinate Tablets 100mg are procured under solicitation SPE2DP-26-T-4238 for acute treatment of migraine with or without aura in adults. The product must be supplied in bottles of nine tablets, stored at 20 to 25°C (68 to 77°F), protected from light, and adhere to a strict 24-month non-extendable shelf life as a Type I (Code M) medical item. Packaging and marking must comply with MIL-STD-2073-1E, MIL-STD-129, and DLA’s Medical Marking Standard No. 1, with palletization governed by DLA Packaging Requirements. The item is subject to FDA regulation and requires referral through EBS for confirmation. Two contract line items are listed: one for one bottle and another for five bottles, both with identical specifications, delivered FOB destination within five days, with no variance in quantity allowed. Delivery is directed to JBER, Alaska, with designated shipping and parcel post addresses provided. The required delivery date is July 24, 2026, and the contract includes detailed logistics codes, unit of issue references, and procurement identifiers. Manufacturer identifiers include NDC codes for Mylan Pharmaceuticals Inc and Golden State Medical Supply, Inc., and all technical and quality requirements referenced must align with the DLA Master List at the time of solicitation or award.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

PSYLLIUM HYDROPHILIThe contract is for the procurement of Psyllium Hydrophilic Mucilloid in 12 gram packets, each containing 25 mg potassium and 5 mg sodium, packaged in units of 30 packets per package, with a total requirement of 19,000 packets across multiple CLINs. The item is regulated by the FDA and must be supplied with the manufacturer’s part number NDC37000-0740-87 under The Procter & Gamble Distributing LLC. The product has a non-extendable shelf life of 24 months, and all packaging must comply with the latest Medical Marking Standard No. 1, which supersedes MIL-STD-129, and must be labeled in accordance with DLA packaging requirements. Each unit must be sealed in a protective container and packed in commercial shipping containers suitable for safe transport by common carrier at the lowest cost. Delivery is FOB destination with zero variance allowed in quantity, and inspection and acceptance occur at the delivery point. The contract requires precise marking, palletization, and traceable shipping methods, explicitly prohibiting parcel post. Delivery schedules vary by CLIN and are set between June 2025 and July 2026, with fulfillment addressed to multiple DoD locations including Camp Pendleton, Camp Kinsler, and the USS Pinckney. Bidders must specify their source and part number, and the contracting officer must refer the bid to a product specialist for FDA-regulated item confirmation. Technical and quality requirements are governed by the DLA Master List, and all documentation must align with the version in effect on the solicitation or award date.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Insect Repellent Supply for DoD UseThe contract entails the supply of 20 boxes of insect repellent standardized under NSN 6840016567707 for use by the Department of Defense, ensuring full compliance with Defense Logistics Agency packaging and delivery specifications. The product is classified under NAICS code 325411, indicating its origin in the manufacturing of other chemical products, and is being procured as a subcontract under the broader defense supply chain. Delivery must adhere strictly to DLA standards to ensure operational readiness and compatibility with military logistics systems. The contract was posted on July 21, 2026, and is tied to the award contract SPE4AX16D9008 with delivery identifier SPE4A626FCWRC, though no specific location or point of contact is provided. The effort supports the Department of Defense's mission-critical need for pest protection in deployment environments.

Defense Logistics Agency

POSTED

DEADLINE

TETRACAINE HYDROCHLThe contract is for Tetracaine Hydrochloride 1% Injection, 20mg/2ml (10mg/ml), preservative-free in 2ml single-use vials, with ten vials per package, requiring refrigerated storage. The item is classified under NSN 6505-01-708-3073 with a unit of issue of a package (PG) and a quantity of one package. It has a non-extendable shelf life of 36 months and must comply with the DLA Master List of Technical and Quality Requirements, including packaging standards per MIL-STD-2073-1E and marking requirements per Medical Marking Standard No. 1, which supersedes MIL-STD-129. The manufacturer is BPI, Inc. with NDC code 54288-0127-10, and the product is regulated by the FDA, requiring a referral through EBS for confirmation. Delivery is FOB destination within 20 days to Fort Campbell, Kentucky, and shipment must be via traceable means, excluding parcel post. Packaging must ensure protection from damage, use commercial containers, and meet DLA packaging requirements, with palletization and marking strictly adhering to specified protocols. The contract was issued under solicitation SPE2DP-26-T-4231 with a response deadline of July 27, 2026, and the required delivery date is March 5, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

in about 20 hours

PSYLLIUM HYDROPHILIC MThe contract is for Psyllium Hydrophilic Mucilloid in sugar orange flavor, supplied in 12 gm packets, with each packet containing 25 mg of potassium and 5 mg of sodium, packaged in units of 30 packets per box. The item is regulated by the FDA and must be procured with the specified manufacturer part number NDC37000-0740-87 from The Procter & Gamble Distributing LLC. It carries a non-extendable 24-month shelf life under Type I (Code M) requirements and must be packaged and marked in strict accordance with Medical Marking Standard No. 1, which supersedes all references to MIL-STD-129. Packaging must meet DLA requirements, including commercial-grade sealed unit containers and shipping containers that ensure safe delivery at the lowest possible rate. The unit of issue is a package of 30s, with a total quantity of 4 packages required. Delivery is FOB destination within 20 days, with zero variance permitted, and inspection and acceptance occur at the delivery point. The shipment is designated for a military vessel, with specific transportation protocols requiring the use of traceable methods and prohibiting parcel post. All labeling, packing, and marking must comply with applicable DLA standards, and bidders must clearly state the source and part number. The contract is issued under solicitation SPE2DP-26-T-4220 with an original delivery deadline of July 23, 2026, and is managed by the Department of Defense’s Medical Supply Chain PHARM FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

in about 20 hours

VERAPAMIL HYDROCHLORIDVerapamil hydrochloride injection is a 5 mg per 2 mL (2.5 mg/mL) preservative-free, single-dose solution supplied in 2 mL glass flip-top vials, with a package quantity of 25 vials per unit. The product is intended solely for intravenous use and must be protected from light during storage and handling. It should be stored at a controlled room temperature of 20 to 25°C (68 to 77°F) in accordance with USP standards. The item has a non-extendable shelf life of 24 months from the date of manufacture, and no more than four months may have elapsed between manufacture and delivery to the government. The NSN is 6505-01-738-0226, and the purchase request number is 7017548722 with a delivery requirement of five days after order award. The contract is issued under solicitation number SPE2DP-26-T-4217, posted on July 21, 2026, with a response deadline of July 27, 2026. The NAICS code is 325411, and the contracting agency is the Department of Defense through the Medical Supply Chain Pharmaceutical FSA. Delivery is to Joint Base Elmendorf-Richardson in Alaska, 99506-4400. The contract incorporates technical and quality requirements from the DLA Master List and applies DLA packaging standards. Covered defense information may apply, and federal regulations require removal of government identification from non-accepted supplies. Primary point of contact is Daniel Porter, reachable by phone or email as listed.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

in about 20 hours

SUMATRIPTAN SUCCINATESumatriptan Succinate Tablets, 100mg in bottles of nine tablets, are procured under solicitation SPE2DP-26-T-4216 for the Department of Defense Medical Supply Chain, with a delivery requirement of five days after award and an original delivery date of July 22, 2026. The item, identified by NSN 6505017278704, is designated as a TYPE I (CODE M) medical product with a strict 24-month non-extendable shelf life, requiring storage at controlled room temperature between 20 to 25°C (68 to 77°F) and protection from light. The product is regulated by the FDA and must be accompanied by appropriate labeling per Medical Marking Standard No. 1 and MIL-STD-129, including barcoded identifiers, lot numbers, and expiration data. Packaging must comply with MIL-STD-2073-1E, utilizing prescribed preservation methods, unit containers, and intermediate packaging codes, with palletization governed by DLA’s RP001 requirements. All shipments must be delivered FOB destination to Fort Stewart, Georgia, or Joint Base Elmendorf-Richardson, Alaska, using the fastest traceable means, explicitly prohibiting parcel post. The contract mandates full compliance with FAR and DFARS clauses addressing labor rights, trafficking prevention, cybersecurity safeguards including NIST SP 800-171, hazardous material handling, and prohibitions on covered defense telecommunications equipment. Offerors must furnish valid UEI and CAGE codes, submit representations on small business status, and provide Safety Data Sheets aligned with Federal Standard No. 313 and OSHA’s Hazard Communication Standard. All invoices must be processed through WAWF, and inspection and acceptance occur at the delivery point with zero tolerance for quantity variance. The solicitation does not disclose unit pricing or total contract value, but specifies two line items totaling three bottles, with delivery scheduled for mid-2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Repackaging and Labeling ServicesThe contract involves the repackaging of fluconazole tablets into containers that meet Department of Defense compliance standards, ensuring proper military-specific labeling with National Stock Number, Technical Control Number, and military identification blocks. This work requires strict adherence to DoD packaging and labeling protocols to ensure accurate traceability, inventory control, and field distribution within military supply chains. The contractor must handle pharmaceuticals under appropriate conditions to maintain product integrity and regulatory compliance throughout the repackaging process. The performance of this subcontract falls under NAICS code 325411 for pharmaceutical and medicine manufacturing and is managed by the Defense Logistics Agency on behalf of the Department of Defense. While specific location details for performance or contact information are not provided, the contract is tied to a defined delivery and award mechanism through DLA’s procurement system, indicating it supports routine military pharmaceutical supply needs. The work is scheduled to be active following a public posting in July 2026, and the nature of the task suggests the contractor must possess experience in regulated pharmaceutical repackaging and familiarity with military logistical requirements.

Defense Logistics Agency

POSTED

DEADLINE

SODIUM CHLORIDE INJECTSodium Chloride Injection is a sterile, nonpyrogenic intravenous solution designated for fluid and electrolyte replenishment, serving as a source of water and essential electrolytes. It contains no antimicrobial agents and is supplied in single-dose containers, intended for medical use under strict aseptic conditions. The product must comply with stringent packaging and marking requirements per Medical Marking Standard No. 1, superseding MIL-STD-129, and must be labeled in accordance with SPE2DP-26-T-4198. Each unit must be sealed in protective packaging to prevent damage or breakage and packed in commercial shipping containers suitable for safe transport at the lowest carrier rate to the delivery point. The product must be stored in moisture barrier overwrap at room temperature (25°C/77°F), avoiding excessive heat, and must maintain a shelf life of 15 months with no more than two months elapsed between manufacture and government delivery. It is manufactured by Baxter Healthcare Corporation under part number 2B1313Q and identified by NSN 6505014622120, with a unit of issue of PG. The contract specifies a single unit quantity of one PG to be delivered within 20 days FOB destination, with zero variance permitted in quantity and inspection and acceptance occurring at the point of delivery. The solicitation under number SPE2DP-26-T-4198, issued by the Department of Defense through the Medical Supply Chain Pharm FSA, requires compliance with the DLA Master List of Technical and Quality Requirements, with the applicable revision determined by the solicitation or award date depending on acquisition size. The product must be procured under the DoD authorized unit of issue, referenced via official DLA documentation. All documentation, including marking and packaging, must strictly adhere to current DLA standards, and technical specifications are incorporated by reference. The point of contact is Meghan Smink, with the place of performance identified as Sea Girt, NJ, 08750-0000, and the response deadline for bids closing in July 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

ERYTHROMYCIN OPHTHALMIErythromycin Ophthalmic Ointment, USP, is a sterile topical medication containing 5 mg of erythromycin per gram in a base of mineral oil and white petrolatum, formulated for ophthalmic use as an RX-only product. Each unit is packaged in single-dose tubes containing 3.5 grams of ointment, with a unit of issue consisting of 24 tubes per package. The product has a total shelf life of 36 months, and upon receipt by the first government activity, it must have a minimum of 31 months of remaining shelf life. Storage requirements specify controlled room temperature between 15°C and 30°C (59°F–86°F), with protection from excessive heat and freezing. All packaging and labeling must strictly conform to Medical Marking Standard No. 1, superseding MIL-STD-129, and commercial packaging must comply with ASTM D3951 unless overridden by DLA’s Master List of Technical and Quality Requirements. The manufacturer is PADAGIS US LLC with NDC 00574-4024-39, and the NSN is 6505-01-189-7090. The contract requires delivery of one package (24 tubes) to Fort Bragg, North Carolina, within 20 days of issuance, with FOB destination and zero tolerance for quantity variance. Delivery must be made via traceable freight methods, excluding parcel post, and packaging must meet all DLA procurement standards including palletization and hazardous material handling per FED-STD-313 where applicable. The item falls under a Type I (Code Q) shelf-life category with a non-extendable 36-month lifespan. The contracting official must submit a referral via EBS to confirm product compliance with FDA regulations, including manufacturer and part number details. The solicitation, issued under SPE2DP-26-T-4260, was posted on July 23, 2026, with a response deadline of July 29, 2026, and the required delivery date is July 14, 2026. All documentation, labeling, and marking must align with DLA’s current technical and quality requirements, and the point of contact for inquiries is James McCullough.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

LORATADINE TABLETSLoratadine tablets 10 mg are being procured in quantities of 2 business units, with each unit containing 500 tablets, for a total of 1,000 tablets under contract SPE2DP-26-T-4248. The product must comply with all technical and quality requirements referenced in the DLA Master List of Technical and Quality Requirements, including packaging and marking standards specified in Medical Marking Standard No. 1, which replaces MIL-STD-129. Packaging must be commercial-grade, with each unit sealed in a container that protects against damage and breakage, and shipped in exterior containers suitable for safe delivery via common carrier at the lowest cost to the destination point. The item is regulated by the FDA and requires storage between 20°C and 25°C (68°F to 77°F), protected from excessive moisture. It has a non-extendable shelf life of 36 months, classified as a TYPE I (CODE Q) item under DLA shelf-life requirements. The manufacturer is OHM Laboratories Inc. with NDC 51660-0526-05, and the distributor is AmerisourceBergen Drug Corp. Delivery is FOB destination within 20 days of contract award with zero tolerance for quantity variance, and inspection and acceptance occur at the delivery point. The NSN is 6505-01-524-9179, and all markings must adhere to the latest MMS No. 1 guidelines available through DLA Troop Support. The contracting official must submit a referral in EBS with manufacturer and bidder details prior to award.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

OMEPRAZOLE EXTENDED-REThe contract specifies the procurement of 20 mg omeprazole extended-release capsules in 90-count bottles, identified by NSN 6505016247068 and NDC 00781-2868-92, manufactured by Sandoz Inc. Each unit must be packaged in sealed commercial containers that protect against damage, with shipping containers meeting commercial standards for safe delivery at the lowest freight rate. Packaging and labeling must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and palletization must adhere to DLA’s Packaging Requirements. The product has a 24-month shelf life, with at least 21 months remaining at the time of delivery to the first government activity. All units are subject to strict DLA Master List of Technical and Quality Requirements, which take precedence over ASTM D3951, and must be shipped via the fastest traceable means—parcel post is prohibited. The drug is FDA-regulated, and bidders must be referred for product specialist confirmation. Deliveries are split across multiple locations including Fort Stewart, Georgia and Fort Campbell, Kentucky, with rigid zero variance in quantity and fixed delivery dates in July 2026. Inspection and acceptance occur at destination, with all markings and documentation required to align with government-specific identifiers and freight instructions provided in full detail for each delivery point.

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

DEADLINE

DEXAMETHASONE TABLETSThe contract pertains to the procurement of Dexamethasone Tablets, USP, 0.5 mg, in unit dose packaging under the National Stock Number 6505-01-045-0451, with a total quantity of 2 packaging groups, each equivalent to 100 tablets. The supplier must adhere to strict packaging and labeling requirements as defined by Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all units must be sealed in protective containers to ensure integrity during shipment. The product, manufactured by Roxane Labs or Hikma Pharmaceuticals USA Inc. under NDC 00054-8179-25, is regulated by the FDA and requires confirmation via EBS referral. It carries a non-extendable shelf life of 36 months and must be marked in full compliance with the latest Medical Marking Standard. Delivery is required FOB destination within five days of contract award, with zero variance allowed in quantity, and inspection and acceptance occur at the destination point. The solicitation is issued under SPE2DP-26-T-4266, with a response deadline of July 29, 2026, and the sole point of contact is James Foggie at DLA Troop Support, with performance directed to Fort Bragg, NC, 28310.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

RINGER'S INJECTION, LACRINGER'S INJECTION LACTATED USP in 1000 mL units, packaged 12 per pack (1 PG), is procured under contract SPE2DP-26-T-4258 with a total quantity of 21 packs to be delivered within 20 days FOB destination. The product is regulated by the FDA and carries a non-extendable shelf life of 30 months as a TYPE I (CODE P) item. Packaging must comply with Medical Marking Standard No. 1, replacing all prior references to MIL-STD-129, and must ensure protection from damage and breakage during transit. Units must be packed in commercial exterior shipping containers suitable for safe delivery at the lowest carrier rate, with labeling and marking strictly following the latest version of MMS No. 1. The product must be stored at room temperature (25°C), with brief exposure up to 40°C permitted without adverse effects, and must be protected from freezing and excessive heat. The manufacturer is B. BROWN MEDICAL INC with NDC number 00264-7750-00 and part number L7500. Inspection and acceptance occur at the delivery point with zero variance allowed in quantity. All technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, with applicable revisions controlled by the solicitation or award date. Government identification must be removed from non-accepted supplies per RQ011, and procurement is subject to covered defense information provisions. Delivery is to Fort Bragg, NC, with primary point of contact Timothy McCauley at DLA.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

IOHEXOL INJECTIONIOHEXOL INJECTION, USP at 300 mg per milliliter in 150 mL polymer bottles, is being procured in boxes of ten bottles each, with a total quantity of 24 boxes required under contract SPE2DP-26-T-4252. The product is classified as a radiological contrast media and must be stored at controlled room temperature between 20–25°C (68–77°F), with excursions permitted between 15–30°C (59–86°F), and must be protected from strong daylight and direct sunlight and not frozen. It carries a non-extendable shelf life of 36 months and must be packaged and marked in accordance with Medical Marking Standard No. 1, superseding MIL-STD-129. Each unit must be sealed and protected against damage, and shipped in commercial exterior containers suitable for safe transport via common carrier at the lowest cost to the designated delivery point at Fort Bragg, North Carolina. The item is subject to Hazard Communication Standard requirements, necessitating Safety Data Sheets aligned with 29 C.F.R. 1910.1200 and compliant labeling prior to award, along with employee training on the updated standards. Packaging must conform to DLA’s RP001 requirements and federal hazardous material guidelines, and if classified as hazardous under Fed-Std-313, must follow TQ requirement IP025; otherwise, commercial packaging per ASTM D3951 applies, though DLA’s technical requirements take precedence. Delivery is required within five days of order placement, FOB destination, with no variance allowed in quantity. The product is supplied by GE HEALTHCARE INC, identified by NDC 00407-1413-65, and must be shipped by the fastest traceable means, excluding parcel post. The required delivery date is July 24, 2026, with solicitation responses due by July 29, 2026.

Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

DEADLINE

KETAMINE INJECTION, VETKetamine Hydrochloride Injection, USP, in 10 mL multiple-dose vials, is a DEA Schedule C-III controlled substance classified for veterinary use, subject to strict handling and storage requirements including storage in a vault at medically controlled room temperature. The item is regulated by the FDA and must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, with all packaging and labeling aligned to DLA’s Packaging Requirements for Procurement RP001. The product carries a non-extendable 24-month shelf life under RS016 requirements, and each unit must be sealed in commercial-grade containers capable of preventing damage, with palletization and exterior packaging conforming to DLA standards for safe transport via common carrier. Deliveries are required FOB destination within 89 days of contract award, with no tolerance for quantity variance, and must be shipped to the specified military medical logistics hub in Kaiserslautern, Germany, or to APO AE 09227-0000, with inspection and acceptance occurring at the delivery point. The contract, identified by solicitation number SPE2DP-26-T-4257 and NSN 6509-01-712-2920, is issued by the Department of Defense under the Medical Supply Chain Pharm FSA, requiring precise adherence to federal procurement and pharmaceutical handling protocols. The item is procured in a single unit of issue, with a required delivery date of July 23, 2026, and response deadline of July 29, 2026. Only approved vendors—Patterson Veterinary Supply, Inc., Covetrus North America, LLC, and Zoetis Inc.—with authorized part numbers may submit bids. All submissions must include manufacturer details and product specifications for FDA referral via EBS, and the item is subject to Covered Defense Information protocols under RD003. Commercial packaging is mandated, with no government identification to be removed from non-accepted supplies per RQ011, and all markings must conform to the latest Medical Marking Standard No. 1 as published by DLA Troop Support.

All Other Health and Personal Care Retailers

POSTED

DEADLINE

ALBUMIN HUMANALBUMIN HUMAN USP 25% in 50 mL vials is specified for intravenous use only, with a concentration of 25% volume to volume, and is heat treated with included administration accessories such as 18 or 20 gauge needles. Each unit must be free of turbidity and stored at room temperature, with no freezing allowed. The product has a non-extendable shelf life of 36 months and is classified as a TYPE I (CODE Q) item under shelf-life requirements. It is regulated by the FDA, and buyers must ensure proper referral through EBS to confirm bidder and manufacturer details, including NDC numbers for KEDRION BIOPHARMA INC and GRIFOLS USA LLC. Packaging must comply with Commercial standards as specified in the procurement document, conforming to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and must be contained in sealed, protective unit containers within suitable commercial shipping containers to ensure safe, low-cost delivery to the destination point. All units must be marked and packaged according to MIL-STD-2073-1E, and the material is subject to RD003 covered defense information provisions. The contract calls for a delivery of exactly 10 packs, each containing one 50 mL vial, totaling 500 mL, to be delivered within five days FOB destination with zero variance allowed. Inspection and acceptance occur at the destination. The solicitation number is SPE2DP-26-T-4249, issued by the Department of Defense’s Medical Supply Chain, with a response deadline of July 29, 2026, and performance is designated for Fort Bragg, NC.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

WATER FOR INJECTIONThe contract specifies the procurement of 10 packages of Water for Injection, Sterile, USP, each package containing 25 sterile 20 mL vials with flip-top closures, for a total of 250 vials. The product must comply with USP standards and be labeled in accordance with the latest Medical Marking Standard No. 1, with packaging conforming to MIL-STD-2073-1E. Storage requirements mandate controlled room temperature between 20 and 25 degrees Celsius, and the item has a non-extendable shelf life of 24 months as per RS016 and RS001 for a Type I (Code M) item. The delivery is FOB destination within 20 days of contract award with zero variance allowed in quantity, and inspection and acceptance occur at the destination. The item is regulated by the FDA, and buyers must submit a referral through EBS including manufacturer and bidder details. Only two approved manufacturers are listed: Hospira Worldwide LLC with NDC 00409-4887-20 and Fresenius Kabi, LLC with NDC 63323-0185-20. The contract is issued under solicitation SPE2DP-26-T-4261, with a response deadline of July 29, 2026, and the NSN is 6505-00-582-5079. All technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, and provisions for removal of government identification from non-accepted supplies and potential covered defense information apply.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

TOLNAFTATE POWDER, UThe contract specifies the procurement of TOLNAFTATE POWDER USP 1% in 45 gram units, identified by NSN 6505014807897 and NDC 57896-0199-45, supplied by GERI-CARE PHARMACEUTICALS CORP. The item is classified as a TYPE I (CODE Q) medical product with a non-extendable shelf life of 36 months and must be packaged in compliance with the DLA Master List of Technical and Quality Requirements, superseding all other standards including ASTM D3951 and MIL-STD-129. Each unit must be sealed in a protective container and shipped in commercial exterior packages suitable for safe delivery via common carrier at the lowest cost, marked in accordance with Medical Marking Standard No. 1, which replaces all prior military marking requirements. The unit of issue is BT, where one BT equals 45 grams, and each shipment must adhere to strict palletization and labeling guidelines outlined in RP001 and other referenced DLA technical directives. The contract includes three separate line items totaling 28 BT (1,260 grams), with delivery deadlines of July 23, 2026, for 24 BT destined to FPO AP 96694, July 27, 2026, for 3 BT to VILSECK, Germany, and one BT to an unspecified location. All deliveries are FOB destination, with zero variance allowed in quantity, inspection and acceptance occurring upon arrival. Shipment must occur via the fastest traceable means, explicitly prohibiting parcel post, and must comply with hazardous material handling requirements per FED-STD-313 and IP025 if applicable. The contract is issued under solicitation SPE2DP-26-T-4256, with a five-day delivery window, and all packaging and labeling requirements must reflect the latest DLA medical standards, ensuring full traceability, regulatory compliance, and readiness for military medical use.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

MAROPITANT CITRATEMaropitant Citrate 160 mg tablets are supplied in blister packs of four tablets per package, with the unit of issue being a package (PG) of four tablets. The product is a veterinary drug regulated by the FDA and must be stored at controlled room temperature between 20–25°C (68–77°F), with allowable excursions between 15–30°C (59–86°F). It has a non-extendable shelf life of 36 months and must be marked and packaged in strict compliance with the latest Medical Marking Standard No. 1, MIL-STD-129, and ASTM D3951, with DLA Master List of Technical and Quality Requirements taking precedence. Packaging must adhere to DLA procurement requirements, including palletization standards, and must not use parcel post; traceable shipping methods are mandatory. The sole delivery point is Fort Sam Houston, Texas, with a delivery window of 20 days and a required delivery date of July 22, 2026. Quantity is fixed at four packages with no variance permitted. Approved suppliers include Patterson Veterinary Supply, Covetrus North America, and Zoetis Inc., each identified by specific part and NDC numbers. All supplies are subject to inspection and acceptance at the destination, and government use only markings apply. The solicitation is issued under contract number SPE2DP-26-T-4255 by the Department of Defense, Medical Supply Chain PHARM FSA.

All Other Health and Personal Care Retailers

POSTED

DEADLINE

SODIUM CHLORIDE INJSodium Chloride Injection in 10 mL disposable syringes, preservative-free and latex-free, is being procured under solicitation SPE2DP-26-T-4254 with a unit of issue of PG, where one PG equals 30 syringes per tray. The product must comply with stringent DLA packaging and marking standards, specifically Medical Marking Standard No. 1, superseding MIL-STD-129, and must be commercially packaged in sealed unit containers to prevent damage or breakage, with exterior shipping containers ensuring safe and cost-effective delivery to Fort Bliss, Texas. The item is regulated by the FDA and requires referral through EBS for confirmation, with no tolerance for quantity variance—exactly one PG must be delivered. The shelf life is strictly 24 months non-extendable and must be clearly marked per MMS No. 1, which is available online through DLA's logistics portal. The delivery is FOB destination with a 20-day lead time from solicitation award, and shipment must occur via traceable freight methods, excluding parcel post. The material is not classified as hazardous under FED-STD-313 and must be packaged in accordance with ASTM D3951 unless overridden by higher-priority DLA technical requirements. Palletization must conform to RP001 DLA Packaging Requirements, and labeling must include all mandated information per MMS No. 1, including the manufacturer part number 106346 from AmerisourceBergen Drug Corp. The contract specifies the delivery point as W8001Z, 0142 CS BN CO A Composite, Fort Bliss, TX, with an original required delivery date of July 27, 2026, and the solicitation closed on July 29, 2026. All technical, quality, and packaging specifications take precedence over commercial standards, and compliance is mandatory for acceptance.

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

DEADLINE